| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |